K

Korea Pharma Co Ltd
KOSDAQ:032300

Watchlist Manager
Korea Pharma Co Ltd
KOSDAQ:032300
Watchlist
Price: 13 100 KRW -0.53% Market Closed
Market Cap: 142.9B KRW

Korea Pharma Co Ltd
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Korea Pharma Co Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
K
Korea Pharma Co Ltd
KOSDAQ:032300
Cash from Operating Activities
â‚©8B
CAGR 3-Years
4%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Cash from Operating Activities
â‚©63.4B
CAGR 3-Years
-24%
CAGR 5-Years
-14%
CAGR 10-Years
-8%
SK Biopharmaceuticals Co Ltd
KRX:326030
Cash from Operating Activities
â‚©103.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Cash from Operating Activities
â‚©151.3B
CAGR 3-Years
-17%
CAGR 5-Years
4%
CAGR 10-Years
55%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Cash from Operating Activities
-â‚©4.3B
CAGR 3-Years
-6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Caregen Co Ltd
KOSDAQ:214370
Cash from Operating Activities
â‚©14.6B
CAGR 3-Years
-22%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
No Stocks Found

Korea Pharma Co Ltd
Glance View

Market Cap
142.9B KRW
Industry
Pharmaceuticals

KOREA PHARMA Co., Ltd. is engaged in the manufacturing of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2020-08-10. The firm's main products include digestive system solvents, antidepressants, blood circulation agents, antidementia drugs, schizophrenia medicines and others.

Intrinsic Value
12 114.43 KRW
Overvaluation 8%
Intrinsic Value
Price
K

See Also

What is Korea Pharma Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
8B KRW

Based on the financial report for Dec 31, 2024, Korea Pharma Co Ltd's Cash from Operating Activities amounts to 8B KRW.

What is Korea Pharma Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
1%

Over the last year, the Cash from Operating Activities growth was 67%. The average annual Cash from Operating Activities growth rates for Korea Pharma Co Ltd have been 4% over the past three years , 1% over the past five years .

Back to Top